PMA device
Vercise PC DBS System, Vercise Gervia DBS System, Vercise Genus DBS System
Boston Scientific Corp · Stimulator, Electrical, Implanted, For Parkinsonian Symptoms (NHL, Class III) · First FDA decision Jan 10, 2019, newest Feb 29, 2024DystoniaEssential tremorParkinson's disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
4
Naming "Vercise PC DBS"
MAUDE reports
0
Brand "Vercise PC DBS", since 2015
PubMed studies
0
Mentioning "Vercise PC DBS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Vercise PC DBS System, Vercise Gervia DBS System, Vercise Genus DBS System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
P150031-S064 · Decided Feb 29, 2024 · 153 days after receipt · Panel Track
Device type: Stimulator, electrical, implanted, for parkinsonian symptoms (NHL) · Neurology & Neurosurgery
- Vercise PC DBS System / Vercise Gevia DBS SystemPMA supplement
P150031-S001 · Decided Jan 10, 2019 · 385 days after receipt · Normal 180 Day Track
Device type: Stimulator, electrical, implanted, for parkinsonian symptoms (NHL) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Non-Implantable Pelvic Floor Electrical StimulatorNational determinationOn the books230.8Updated Aug 17, 2023
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Vercise PC DBS", any status and sponsor, newest update first.
University of Alabama at BirminghamAcademic, hospital or other
NCT03353688 · 31 participants · Start Nov 3, 2017 · Primary completion Aug 15, 2022
Device: Boston Scientific Vercise PC IPG with directional DBS lead · For: Parkinson Disease
Sites: Birmingham, Alabama
Universitaire Ziekenhuizen KU LeuvenAcademic, hospital or other
NCT05708729 · 32 participants (planned) · Start Jan 24, 2023 · Primary completion Apr 2026
Device: MCS surgery for CPSP; Vc-DBS surgery for CPSP · For: Central Post-stroke Pain; CPSP
Sites: Leuven, Belgium
University of Alabama at BirminghamAcademic, hospital or other
NCT03409120 · 38 participants · Start Jan 1, 2018 · Primary completion Jun 30, 2021
Device: Boston Scientific Vercise PC IPG with directional DBS lead · For: Dystonia-Parkinsonism, Adult-Onset; Parkinson Disease
Sites: Birmingham, Alabama
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Vercise PC DBS", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NHL
1,848 reports: 183 malfunction, 1,620 injury, 43 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Boston Scientific Neuromodulation Corporation
Z-2340-2025 · Started Jul 8, 2025 · Posted by FDA Aug 19, 2025
Reason given: Resistance and difficulties could occur while closing the retaining clip locking mechanism, which is part of a burr hole cover kit, which is part of a Deep Brain Stimulation (DBS) system, which may lead to procedural delay, or lead-migration-which may require additional surgery.
Cause as FDA categorized it: Component change control · Device type: Stimulator, Electrical, Implanted, For Parkinsonian Symptoms (NHL)
- Vercise Deep Brain Stimulation Systems Surgical Implant Manual, Document Number: 92328632-09Open, Classified
Boston Scientific Neuromodulation Corporation
Z-2558-2025 · Started Jul 8, 2025 · Posted by FDA Sep 12, 2025
Reason given: Wire break(s) have occurred in rechargeable deep brain stimulation implantable pulse generators, implanted in the submuscular pectoral location. Wire breaks prevent successful stimulation, thus requiring device removal/replacement and users may experience high monopolar impedances, undesired sensation, loss of...
Cause as FDA categorized it: Labeling design · Device type: Stimulator, Electrical, Implanted, For Parkinsonian Symptoms (NHL)
- Vercise Genus Deep Brain Stimulation (DBS) Implantable Pulse Generator IPG: R16 IPG KIT, REF: M365DB12160, and R32 IPG KIT, REF: M365DB12320Open, Classified
Boston Scientific Neuromodulation Corporation
Z-1890-2024 · Started Apr 18, 2024 · Posted by FDA May 24, 2024
Reason given: Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) may experience routine system check during IPG charging, which may cause device reset. The device reset could lead transient loss of stimulation; patients may experience undesired sensations, transient worsening of movement disorder symptoms, which may...
Cause as FDA categorized it: Device Design · Device type: Stimulator, Electrical, Implanted, For Parkinsonian Symptoms (NHL)
1 more recall records with a free account
Published research
The most relevant PubMed records for "Vercise PC DBS"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NHL.
- Vercise Genus DBS System, Vercise Gevia DBS System, Vercise PC DBS SystemBoston Scientific Corp · PMA 2024
- Vercise Deep Brain Stimulation (Dbs) SystemBoston Scientific Corp · PMA 2026
- Vercise DBS System / Vercise PC DBS SystemBoston Scientific Corp · PMA 2018
- Activa®, Percept and SenSight Deep Brain Stimulation Therapy SystemMedtronic, Inc. · PMA 2025
- Vercise DBS ControllerBoston Scientific Corp · PMA 2025
- Vercise S8 AdapterBoston Scientific Corp · PMA 2023
- Vercise Genus Deep Brain Stimulation (DBS) SystemBoston Scientific Corp · PMA 2021
- Vercise Gevia DBS System and Directional Lead-only SystemBoston Scientific Corp · PMA 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.